THIN® is a prescription-only compounded semaglutide oral spray for eligible patients transitioning off injectable GLP-1 therapy.
Prescription-only. Compounded medication. Not FDA-approved. Dispensed only if a licensed provider determines it is medically appropriate.
Many people regain a meaningful share of lost weight after stopping injections as appetite returns. THIN is built to support the phase that comes next — needle-free.
A simple spray under the tongue — no needles, no injection-site routine.
No refrigeration required. Pocket-sized and easy to take on the go.
Provider visit, medication, and shipping included. No insurance required.
Complete a quick, free medical history form for your provider.
Connect with a licensed provider through a simple online conversation.
If appropriate, your compounded medication ships free to your door.
Payment does not guarantee that a prescription will be written or dispensed.
THIN is a 503A compounded semaglutide oral/sublingual spray — prescription-only and patient-specific. It contains semaglutide, the same active ingredient class associated with Ozempic® and Wegovy®. THIN is not FDA-approved.
THIN is a needle-free maintenance and appetite-support option for eligible patients — complementary to the GLP-1 landscape, not a replacement for all injectable therapy. Your provider advises what's right for you.
No. Your information is reviewed independently by a licensed provider, and medication is only prescribed and dispensed if it is medically appropriate.
Start your evaluation today. Needle-free, prescription-only GLP-1 maintenance, reviewed by a licensed provider.
Start Your THIN Evaluation